Skip to main content

Anti-Cancer Drug Design is now published as Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.

Publisher: Cognizant Communication Corporation

Volume 12, Number 1, 1997

Toxicological properties of several novel oligonucleotide analogs in mice
pp. 1-14(14)
Authors: Henry, SP; Zuckerman, JE; Rojko, J; Hall, WC; Harman, RJ; Kitchen, D; Crooke, ST

Favourites:
ADD

Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer
pp. 15-33(19)
Authors: Fulmer Shealy, Y; Frye, JL; Riordan, JM; Hill, DL; McPhillips, M; Wille, JJ; Sani, BP; Kalin, JR; Eto, I; Grubbs, CJ

Favourites:
ADD

Bis(7-amino-4-azaheptyl)dimethylsilane: a new tetramine with polyamine-like features. Effects on cell growth
pp. 35-48(14)
Authors: Delcros, J-G; Vaultier, M; Le Roch, N; Havouis, R; Moulinoux, J-P; Seiler, N

Favourites:
ADD

Alkylation specificity for a series of distamycin analogues that tether chlorambucil
pp. 49-60(12)
Authors: Wyatt, MD; Lee, M; Hartley, JA

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more